Immediate Impact
10 standout
Citing Papers
The interplay between cytokines, inflammation, and antioxidants: mechanistic insights and therapeutic potentials of various antioxidants and anti-cytokine compounds
2024 Standout
The estimands framework: a primer on the ICH E9(R1) addendum
2024 Standout
Works of Ben Hardwick being referenced
A phase II trial protocol of Tocilizumab in anti-TNF refractory patients with JIA-associated uveitis (the APTITUDE trial)
2018
A randomised controlled trial of the clinical effectiveness, safety and cost-effectiveness of adalimumab in combination with methotrexate for the treatment of juvenile idiopathic arthritis associated uveitis (SYCAMORE Trial)
2014
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Ben Hardwick | 395 | 271 | 228 | 16 | 550 | |
| Deborah W. Kredich | 71 | 234 | 166 | 14 | 643 | |
| Christina F. Pelajo | 77 | 234 | 103 | 16 | 477 | |
| Pirjo Tynjälä | 211 | 477 | 241 | 15 | 619 | |
| Erdal Diri | 75 | 94 | 201 | 13 | 532 | |
| T Southwood | 16 | 188 | 82 | 22 | 462 | |
| Eric Mann | 240 | 18 | 36 | 19 | 481 | |
| Stéphane Debeugny | 38 | 22 | 58 | 18 | 516 | |
| Jan S. Stilma | 326 | 39 | 42 | 16 | 538 | |
| Abdulkader Daif | 43 | 81 | 64 | 23 | 476 | |
| Lisabeth V. Scalzi | 11 | 47 | 231 | 20 | 532 |
All Works
Login with ORCID to disown or claim papers
Loading papers...